- By PTI
- Mon, 18 May 2026 03:41 PM (IST)
- Source:PTI
Q4 Earnings: Strides Pharma Science Ltd on Monday reported a 51 per cent rise in consolidated net profit at Rs 129.28 crore for the fourth quarter ended March 31, 2026, driven by a good growth in its main markets excluding the US. The company had posted a profit of Rs 85.62 crore for the year-ago period, Strides Pharma said in a regulatory filing. Revenue from operations in the quarter stood at Rs 1,323.47 crore as compared to Rs 1,190.39 crore in the year-ago period, it added.
In the fourth quarter, revenue from main markets excluding the US was up at Rs 645.8 crore as compared to Rs 480 crore in the year-ago period. The US market revenue was at Rs 646.7 crore, down from Rs 651.5 crore in the year-ago period, the company said in an investor presentation.
Total expenses in the quarter under review were higher at Rs 1,178.59 crore as compared to Rs 1,071.71 crore in the same period a year ago, the company said.
In FY26, consolidated net profit was at Rs 574.52 crore as compared to Rs 3,597.51 crore in FY25, which was boosted by a profit after tax from discontinued operations of Rs 3,188.11 crore. Revenue from operations stood at Rs 4,858.68 crore as against Rs 4,565.34 crore.
Zydus Wellness Q4 Results
Zydus Wellness Ltd on Monday reported a 5.75 per cent decline in consolidated net profit at Rs 162 crore for the fourth quarter ended March 31, 2026, impacted by higher expenses and taxes.
The company had posted a net profit of Rs 171.9 crore for the year-ago period, Zydus Wellness said in a regulatory filing. Total revenue from operations in the fourth quarter stood at Rs 1,484.7 crore as compared to Rs 913.1 crore in the year-ago period. Total expenses were at Rs 1,308.6 crore as against Rs 740.5 crore.
Total tax expenses were also higher at Rs 15.3 crore as compared to Rs 1.5 crore in the March quarter of FY25.
In FY26, the consolidated net profit was at Rs 197.2 crore as compared to Rs 346.9 crore a year ago. Total revenue from operations stood at Rs 3,961 crore as against Rs 2,708.9 crore.
Disclaimer: This story has been directly published from the agency feed (PTI). No changes have been made except the headline.
